Shanghai Pharmaceutical Group Co., Ltd

Shanghai Pharmaceutical Group Co., Ltd. is the only listed pharmaceutical company in China that takes a leading position in both pharmaceutical products and distribution market. With innovation as its long-term direction, the company is committed to providing safe and effective therapeutic drugs for major diseases and chronic diseases. In 2012, R & D investment accounted for 4.72% of the company's pharmaceutical sales revenue. The company has established the research and development system of the branch of the General Institute of the group with Academia Sinica as the technical core, has one national enterprise technology center and ten provincial and municipal enterprise technology centers, and has been selected into more than ten national science and technology major projects of "major new drug creation". Using the open research mode, the company has established a strategic alliance for innovative drug research and development with Shanghai Institute of pharmacy, Chinese Academy of Sciences, established a joint laboratory with China Pharmaceutical University and Shenyang Pharmaceutical University, and cooperated with Mitsubishi Tianbian Pharmaceutical Co., Ltd. of Japan and Shanghai Fudan Zhangjiang bio Pharmaceutical Co., Ltd. to carry out innovative drug research and development. At the same time, the company also started to develop innovative drugs through project introduction and cooperative development Enter the field of therapeutic antibody.

Shanghai pharmaceutical manufacturing covers chemical and biological medicine, modern Chinese medicine and health products, medical devices and other fields, products focus on cardiovascular, systemic anti infection, digestive system and immune metabolism, neuropsychiatric, anti-tumor five treatment areas, producing tablets, gels, powder injection (including freeze-dried), small volume injection, eye drops, aerosol, gel and so on 20 kinds. The above dosage forms, more than 100 million products 20. The company's Xinyi, Leishi, Longhu, Qingchunbao, Huqingyutang, Cangsong, Guofeng, Shenxiang and other brands are well-known trademarks in China. The company strictly implements the requirements of China's new version of GMP in drug production, and a number of APIs or preparations have passed the quality certification of who, FDA, EU and other developed countries.

Shanghai Pharmaceutical's distribution network is centered on the three key regions of East China, North China and South China with the most developed economy in China, radiating all over the country, and its business scale ranks second in the country. The company's distribution business is mainly hospital sales, and has carried out cooperation with more than 40 multinational pharmaceutical companies around the world. The company's vaccine, high-end consumables, DTP (direct delivery of high-value drugs) and SPD (pharmaceutical logistics management technology) and other new business development are in a leading position in China. The company's distribution services are gradually moving towards modern hospital service solutions with supply chain extension services and clinical support services as the core, providing terminal solutions, special logistics and information services for hospital customers.

Shanghai Pharmaceutical retail has many famous brands such as Fahrenheit, leiyunshang, Yu Tiancheng, life insurance Tian, Raymond, Keyuan Xinhai pharmacy, covering 12 provinces, municipalities and autonomous regions in China, with a total of 1792 stores. In 2012, the company's drug retail sales scale ranked among the top five in the national drug retail industry, and Shanghai Huashi pharmacy is the enterprise with the largest number of pharmacies in East China. Shanghai Pharmaceutical's retail business includes chain drugstores, joint drugstores, DTP drugstores and other formats, and actively develops e-commerce to realize online sales.

Shanghai Pharmaceutical advocates the core values of "innovation, integrity, cooperation, tolerance and responsibility". It is committed to persevere, improve the quality of people's healthy life, and strive to build a leading brand pharmaceutical manufacturer and health service provider with respect and industry reputation.